Auris Medical Announces Positive Interim Data from TRAVERS Phase 2 Study with AM-125 in Vertigo
Dose dependent improvement in balance tests over placebo in Part A of TRAVERS trialImprovement 1.9 to 2.4 times greater with […]
Dose dependent improvement in balance tests over placebo in Part A of TRAVERS trialImprovement 1.9 to 2.4 times greater with […]
SAN FRANCISCO, Sept. 03, 2020 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development […]
MOUNT HOREB, Wis., Sept. 03, 2020 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the […]
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) — Envision Solar International, Inc., (Nasdaq: EVSI, EVSIW) (“Envision Solar,” or the “Company”), […]
MONTREAL, Sept. 03, 2020 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce its Phase 1 exploration […]
TORONTO, Sept. 03, 2020 (GLOBE NEWSWIRE) — Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRSF) (“Ayr” or the “Company”), a vertically-integrated […]
AUSTIN, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s […]
SUNNYVALE, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — Proofpoint, Inc., (NASDAQ: PFPT), a leading cybersecurity and compliance company, today announced […]
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the […]
PLANO, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) — DZS (NASDAQ: DZSI), a leading enabler of the hyper-connected world, has partnered […]